Orofacial Myofunctional Therapy to Treat Pediatric Obstructive Sleep Apnea in Children Aged 6 to 12

What this Trial Is About

Obstructive sleep apnea OSA is a common condition affecting children, impacting their overall health and quality of life. This research aims to evaluate orofacial myofunctional therapy as a new treatment option for pediatric OSA. The study focuses on children aged 6 to 12 years with OSA, especially those who may have limited treatment options beyond standard approaches like surgery. The study involves a 12-week program of orofacial myofunctional therapy, which includes exercises designed to correct abnormal mouth and tongue functions and strengthen muscles that keep the airway open. Participants will receive this therapy to see if it improves their sleep apnea symptoms and related quality of life outcomes. During the study, children will be assessed before and after the 12 weeks of therapy using various tests, including sleep studies, muscle strength measurements, and quality of life questionnaires. Researchers will track changes in apnea-hypopnea index AHI, orofacial function scores, sleep quality, and patient-reported outcomes to understand the potential benefits and effects of this therapy.

Oromyofunctional Training: an Innovative Rehabilitation Program for Pediatric Obstructive Sleep Apnea